The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon

Slaughter and May

Living Wage
ONE BUNHILL ROW, LONDON, EC1Y 8YY, ENGLAND
Tel:
Work 020 7600 1200
Fax:
Fax 020 7090 5000
DX:
11 LONDON CHANCERY LANE WC2
Email:
Web:
www.slaughterandmay.com
Beijing, Brussels, Hong Kong, London

Richard Smith

Tel:
Work 020 7600 1200
Email:
Slaughter and May

Work Department

Corporate

Position

Partner. Richard has a broad corporate and corporate finance practice with particular experience in public and private M&A, and equity capital markets work. He has also developed specialist expertise in the utilities, pharmaceutical, insurance and banking sectors.

Career

Trained Slaughter and May 2001-03; qualified 2003; associate 2003-10; partner 2010 to date.

Education

Amery Hill Comprehensive School, Alton, Hampshire; Magdalen College, University of Oxford.


London: Corporate and commercial

Equity capital markets

Within: Equity capital markets

Known for its excellent client base and high-value mandates,¬†Slaughter and May's 'hugely responsive, extremely commercial' team 'takes complex problems, devours them and produces an answer'. It primarily advises issuers on equity capital markets matters, from germination to IPOs and post-listing work. Real estate, financial services and oil and gas have been especially busy sectors recently;¬†Susannah Macknay¬†and¬†Jeff Twentyman¬†acted for Glenveagh Properties on its ¬£550m IPO on the ISE and the LSE, and Macknay ‚Äď along with¬†Steven Galbraith¬†and¬†Richard Smith ‚Äď assisted Kosmos Energy with its secondary listing on the LSE.¬†David Johnson¬†is 'brilliant for straightforward, pithy advice'; he and the 'focused, upbeat'¬†Sally Wokes¬†acted for Segro on a ¬£573m rights issuance. Other clients of the 'exceptionally good' practice¬†include Ultra Electronics Holdings, Atlas Mara and HomeServe. The 'bright, incisive'¬†Nilufer Von Bismarck¬†heads the department.

[back to top]

London: TMT (technology, media and telecoms)

Pharmaceuticals and biotechnology

Within: Pharmaceuticals and biotechnology

Corporate, commercial, transactions and IP are the core areas of focus for Slaughter and May. Susie Middlemiss co-heads the team and has expertise in disputes and IP work. Fellow practice head David Johnson focuses on corporate and commercial transactions and assisted GlaxoSmithKline with the $619m sale of its 6.2% stake in Aspen Pharmacare. Alongside Johnson, corporate transactions expert Simon Nicholls worked with Actelion on its sale to Johnson & Johnson. Corporate and commercial law specialist Richard Smith advised Immunocore on its collaboration with the Bill & Melinda Gates Foundation, which will focus on developing treatments for HIV and TB using T-cell receptors.

[back to top]


Back to index

Legal Developments in London

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to